adult content

healthcare medical

corporate

government public service

corporate business

English

__client_uat_XJG31BwQ

_gcl_au

__client_uat

gtm.js_au

_ga_3XM7T03PEY

ph_phc_yqsXnLTTtQ8fGwrw9y22y1aWezyu8BzvyQAf1Gkr8su_posthog

You're looking at domain 'vibetrader.com' on the commercial generic top-level domain (.com). Its registrable label 'vibetrader' stretches across 10 characters containing 4 vowels alongside six consonants. Word splitting yields 2 words: vibe, trader. Median word length comes out to five characters. No strong language cues emerged from the frequency lists.

html/88/bf/88bffde4-0666-4a96-8766-21cbcfd1d272.html.gz

inline; filename="4c9affa5bc8f420e-s.p.woff2"

inline; filename="webpack-2f2ac189d3fa8301.js"

inline; filename="4bd1b696-cc729d47eba2cee4.js"

inline; filename="9da6db1e-489358abc77db09e.js"

inline; filename="5964-e9a27e05c20d1e6b.js"

inline; filename="main-app-ef5e0255a0e0292c.js"

inline; filename="2256-313405c0b02d0c86.js"

inline; filename="3965-94f3fbfa6e85419f.js"

inline; filename="4391-54b9d17e6b1a0052.js"

inline; filename="6671-24139d96056a6e31.js"

inline; filename="1925-2f5cd74229e99452.js"

inline; filename="1859-70b983a36ccbddb0.js"

inline; filename="5043-2a5f351f393960fe.js"

inline; filename="layout-6a22684d8d80ace6.js"

inline; filename="error-47f7eec85e767237.js"

inline; filename="6874-414075bb21e16c80.js"

inline; filename="4064-7b22641ff6a9adf5.js"

inline; filename="9905-0e99396b57501177.js"

inline; filename="6430-fc9f529a27cc0590.js"

inline; filename="page-6fe57742c3d25052.js"

appId=cid-v1:a894a21c-0197-44e5-b203-3cbc01252c82

script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascnsrsggc:197:0

script-src 'none'; form-action 'none'; frame-src 'none'; report-uri https://csp.withgoogle.com/csp/scaffolding/ascnsrsggc:165:0

frame-ancestors 'self' chrome-extension://alhgpfoeiimagjlnfekdhkjlkiomcapa chrome-extension://ececkagaccnfmkopaiemklekhoimmgpn *.salesforce.com *.lightning.force.com; report-uri https://o101058.ingest.us.sentry.io/api/222018/security/?sentry_key=86bb17dd8c2449719dd6b498f3431191&sentry_environment=production&sentry_release=3df12275c677406edfb80bc8855dfd4b71c59b70

appId=cid-v1:a449a586-8786-487f-a449-dc1b282a2628

ffd7f6e783e65bee2dc829c11f8d0483e4ffb4d255a40747df716615ee4b87df

0b3411770f7a56146ab40af5efb37a43678c402bf7c688dfefbaeb7785bbdf86

4ef6b96bde5d4be67cbcee758fa9d4e6648118cba1f4dbb7d52e6a953342066a

c382df3dab1b557cc2e49df81b8e3328cb7d7c0287cace83a7ae6325e7535e84

438c2f638a0375bed10bd46334b3750ab41fc1a8e29a9f1e341cb85679e5f151

b0e3fb355488c3162da208439dc9117eb83de29aeab9832d092eb92f6fd6bff5

b1d04a050a76efdb510e2173889f33743f67520d226787487ea8a24db2d078a0

95d543b912ae24b17d2314ac14ad28fff10fca1b7b0b7aeda37af92cf0282cb0

39c8ef7722c1c637d74c421a47433a668644fe97f28e2033f5de965fccd18cd8

08873e32f9f222b3ae9b111af843cbed6af430219639d9ca2c2bc6c6177ca098

8a7fb753c1710c1de3bd59e9c1a0cb2934d776c95a7ece5d8091c79286add32c

f0b192c6af6d2f64298a690587631434e92596fd1b431d896480a36c42e1dd95

d563ef27c91b02140bf3886d152436483adaae82e4f02ec02f3254c9668429d0

59089bf7f2b66e49d40493744841c7fd46c1d39a0c1f9a3e49635fc03a823c2e

d92e69c91eeb10ec1558b79376a35520ead6e358811319366c6c28a4fb88d5a0

be24abd88a3fc0ce5319b6c55e3b3eeab137f997ad98c7d1a7f634fb9a03fe8a

15da39c99315673ddb84acc9a345a389acf3b1cbc97d349645ec56dd80867c01

d202b19fbd9340a242b19b3fc3c9ce93481099a82bcddf5210a3a8c3c2075bf9

a944749699d0ce20560fab60fb76aef0a75001d4736d3fab3ee7aaa602422daa

dfcba72a1291e44eee3a7fb55d7d6b6a88f6550844954e237a9201d14c703777

9cdf17fc6fd7152dab9de07bf957963036163b1d4d23de9c035a094157533e9e

9afce9b466a22c29ab18a15581d5da3286f4377be6e0ed3b6c6928664da51f26

6e50c896e3b4b8721e213c57f98be93a6cb39b855848ec162e897c0ee98a2e0e

2836ab217b40db69b67ced179d04727fbd1f099e48608b15da409439a41ad7df

073d37fbec70913e30c878fbd7bb9273e3ddf5c4d3b0cab88f4d481b82fcf5ba

074a1962d612d6dc592109650a97e684534d2b112354b2abdb237ba0530ec5a7

ca699ca55b48b468c14029f1c4111e011ea6f840b09dbe1ce9e7ee45ccc1f14c

e39c1e1a3d9176830821ef63856b3150d4b8ced964fb3b2098c602c097d65b99

7815e1a4287c67528b9ebd966b22499041e637158573b52476d6d801f2572cf7

5f3aa62f390a95e0305c4fb6ed6b11bdb09a69da8ba334db3437c42e48a91997

c35ace995bb9b8b0cc5180788a4fe71519e3b17531758daa94734386dea0e55d

a236defd861c4d5c3daff5f76f774fa8207980aa8df746aefa493ada81fbefef

8a64109ed33fc8bd67cee197dfd259853100483f813a5fa67763789622781cd8

bde9daae14c6daca721c33351876beb0298c8f2a2ddfe8af8ddca31c64d7f8ae

3736a6ed0be800574616f41a03c5e14c8be5e3b0fc4b8399af41739f4f2b3bbe

ccc9bafa67750ddfbf559dfe9f5356d301199b6cd245dc7fb402302c587a22b6

89da8cb1e99ce0c9e9bb76fe266844d365f157e077a76c36fc1ec87bef519161

b79022e54da6b4e1f4ad388fa5247c14665cd17bfc4ceba082e88c1fbc2c0fb6

b17a691eebb7f5211d4f82ef8814c5baebd8f0b91cb44fc40722f75939aa05d6

7508b39096f6c468d9f75293b80abbf0a2402f5343be3de1a929f87ff1709920

9f808da7f8c19ccbca9d68f9f7cbadd783724adb49efc7b4cef72acaa4c33f45

3b22d039e957170d575718cff58b398712f0760af1cfe4444d3e50eb5f4b631e

7ea7399b5f0145aef6ad9442cbc0562274fc89632b1e53ca3829dc2925bfcc9b

425ff740cb8f5b122de92ff210e40f369d3e53bbd858a29c5da0d2b611d742ce

f10ab52da90f81903639b8851deffce2371fd6a399ad872e5da265705d6269f0

27c8103ebb82a85c38d4181cf3f5d184d0487fe7588dea3315092e99d77ac1ac

b937d08a12e06cb68a72106f07661a6f3bca0bc8dfc25fdebdd4a80b456f5bcc

ce08becfeb5c37258f4ac98419948bda5f62e4d206fae2bdb6402c93fbfe4647

4cc40b9194955558152ed4a455af3acce10efacb59a933453681a5d6e2a61f06

9a300fbc92910404cfc2d0e40ded6dfadc3699b9958e05d57d822625f780773f

2db54c8168fbeb38bb82d5a2c780f7b652f6249bc5485f85b335f1a45163dd62

093f2e273d901adb9aea706750d40d3c0e3417979fac263056a4d1232764a33b

3814cddd18b2095e01abb745a99e5ada90178e709c09879324c3b623f2d829ea

a2861ed57dea9ddc5f73a68d709cbd11b3c0da097cc2b46de78722c852bcc674

e23a7b316a4b683ba61459950d578fc42445800899a95200ae69109a5e5976d1

7beefb1c3ab38e4e9709443e244f229f86cd1f48c5f56075d4b5c8e0f6e7dc89

52cca12df4bf47eb90425a44ab174560b45123e8cde29a25097e154874cbc952

1fc776aa20cfab9a78976894026e76cb70330451041c234e36d10115c2c63262

da33310b37b56d4fc7f5cf58993eddd0525674dfd5ce7039c6f694eb7eb3bb41

9f8eaf3f0496b8c0b45bbd37a41a1f226bfcd99dbac68e0b5f29afd04f5c68f9

d647bc4c9c9a63e6c63e02607b6e8fb8cd5774c4f72ec08f7e332ff307f89b77

9f34b517c8b2b88274a846fd232d489e4b9b575c540245514e549d224411e4a5

a0df674b9d018e528c77046f0dd787bfa1a4f98fa918de68e072a2a9f82aa8db

7ea9d14f0e7d076daac384ab3a1271a038eacb33d4cd6faaaaff97204d213a50

9d4a8b3f869b36922ddbab2dacdaf3518d564fe4b1fa2c1d3d55e82cccf7fa3c

b8b83a3ceb937671f69e5e0f3c35d0437bdfce49d06cf8622f9c5f8488b96ac6

42d6ca493b0ed6a78276607e9c51652c059a56e09069c60eebe03e2b4db46b32

4c6711b216187695c9666a42b7f6f391cc3280e051bd31e155c577360104fce9

776255143bb14fc260bf6bbb11b34e403b4428011d5998205d0a4f411bb59d6b

53313468454166d2175e5310eaa3aa8688762330d1d70546a334705b369e67ba

1afe816f8733353aa4845e52e2e8a7ab558cfc598bfdb35671edb8f5548e62f7

3af73e862e7eb997670ab6604bb94252e608f78d334fae04388728068f99d15c

eac829ad84ba96bd59dce891e9d90446c59da29b9640f1dfa4b6af65ccfad136

61bd610086a24386bf7c729f1648ac88f6a19b290394d30ab5f3e8e971bf368f

e29b02c81f1c85ca37809aed7061991b6128c0a9cee7c2ec5ce4bb599fd9f6be

2d3e6769de172d4e941d1a5ed7fbdf5084225a312a77faa82a023964e91ff28b

5751290b8e96fdef858c9b66b2b410ef30d14d76325d7e19867512ae87244134

c3a3a40357a7007e520c5a9b812455ed86a5a0ffafec75597322a121c6483667

40f9daf9a2601bdc807774e4a43ab3f5b9375ed3532b1275177207541aa9e6ed

f8bc83ec98040307384b139a87a850550936185963d93cf4306eb13519d37963

b6e91dfa879b067254e7d9dec9eff2ca00dd0c5506e6761b7b64a7291f9db517

b945f43285e80e9daf755ad84a7d8c90fc062bf92b68a6e52f514ab7e1d9b7ba

5adb24e694696fbd2f700a0f576fd4106f99ae613bf261dc6230173c05068436

0a244e6b07c59a3d6af63092b06a0dbb019a4833d2535a96434c69d4eb15a972

f158da4b9371d073bc1d9cca38044807cb946788682b45acc28a6cadbba77aba

381b16c838c8998fb5755e036de0f626bc3855b105ee33fae0a547aebd1da1bb

e851e1f4b5177c96a7f8f2ac835d376960ec06f9d8e5d080217013b5845585b0

width=device-width, initial-scale=1, maximum-scale=5, user-scalable=yes

viewport

next-size-adjust

Eli Lilly announced that it will file for approval of its next-generation obesity drug, retatrutide, in the first quarter of 2027, following successful results...

description

author

financial news,market analysis,trading insights,high impact

keywords

referrer

creator

publisher

robots

index, follow, max-video-preview:-1, max-image-preview:large, max-snippet:-1

googlebot

classification

financial news, market analysis, trading insights, high market impact, lilly, file, approval, nextgeneration, obesity, drug

news_keywords

googlebot-news

format-detection

google-site-verification

msvalidate.01

Eli Lilly to File for Approval of Next-Generation Obesity Drug Retatrutide in 2027 After Positive Late-Stage Trials

https://vibetrader.com/news/77dad60c-f10c-44d9-a14e-fd54e4165c9e

https://vibetraderapp.blob.core.windows.net/vibe-news-images/news_0a80ee44-a2d9-4307-af9d-61847f78ab55.png

twitter:card

twitter:title

twitter:description

twitter:image

NameCheap, Inc.

VIBETRADER.COM

Akamai Technologies, Inc.

Steven Jay Schecter

AKAMAI

AI-powered automated trading platform with real-time analytics, risk management, and no-code strategy builder for smarter trading.

Vibe Trading

Starter Plan

Professional Plan

Enterprise Plan

Vibe Trading Platform

Vibetrader

(function(w,r){w._rwq=r;w[r]=w[r]||function(){(w[r].q=w[r].q||[]).push(arguments)}})(window,'rewardful');

((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","system",null,["light","dark"],null,true,true)

Home

News

(self.__next_s=self.__next_s||[]).push([0,{"children":"(function(w,r){w._rwq=r;w[r]=w[r]||function(){(w[r].q=w[r].q||[]).push(arguments)}})(window,'rewardful');","id":"rewardful-queue"}])

(self.__next_f=self.__next_f||[]).push([0])

self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[87555,[],\"\"]\n4:I[31295,[],\"\"]\n6:I[59665,[],\"OutletBoundary\"]\n8:I[74911,[],\"AsyncMetadataOutlet\"]\na:I[59665,[],\"ViewportBoundary\"]\nc:I[59665,[],\"MetadataBoundary\"]\nd:\"$Sreact.suspense\"\nf:I[28393,[],\"\"]\n"])

self.__next_f.push([1,"10:I[27016,[\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4391\",\"static/chunks/4391-54b9d17e6b1a0052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6671\",\"static/chunks/6671-24139d96056a6e31.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1925\",\"static/chunks/1925-2f5cd74229e99452.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1859\",\"static/chunks/1859-70b983a36ccbddb0.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5043\",\"static/chunks/5043-2a5f351f393960fe.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"7177\",\"static/chunks/app/layout-6a22684d8d80ace6.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"PromisifiedAuthProvider\"]\n"])

self.__next_f.push([1,"12:I[25839,[\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4391\",\"static/chunks/4391-54b9d17e6b1a0052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6671\",\"static/chunks/6671-24139d96056a6e31.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1925\",\"static/chunks/1925-2f5cd74229e99452.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1859\",\"static/chunks/1859-70b983a36ccbddb0.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5043\",\"static/chunks/5043-2a5f351f393960fe.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"7177\",\"static/chunks/app/layout-6a22684d8d80ace6.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"ClientClerkProvider\"]\n"])

self.__next_f.push([1,"16:I[22044,[\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4391\",\"static/chunks/4391-54b9d17e6b1a0052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6671\",\"static/chunks/6671-24139d96056a6e31.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1925\",\"static/chunks/1925-2f5cd74229e99452.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1859\",\"static/chunks/1859-70b983a36ccbddb0.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5043\",\"static/chunks/5043-2a5f351f393960fe.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"7177\",\"static/chunks/app/layout-6a22684d8d80ace6.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"QueryProvider\"]\n"])

self.__next_f.push([1,"17:I[99304,[\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4391\",\"static/chunks/4391-54b9d17e6b1a0052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6671\",\"static/chunks/6671-24139d96056a6e31.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1925\",\"static/chunks/1925-2f5cd74229e99452.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1859\",\"static/chunks/1859-70b983a36ccbddb0.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5043\",\"static/chunks/5043-2a5f351f393960fe.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"7177\",\"static/chunks/app/layout-6a22684d8d80ace6.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"ThemeProvider\"]\n"])

self.__next_f.push([1,"18:I[55860,[\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4391\",\"static/chunks/4391-54b9d17e6b1a0052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6671\",\"static/chunks/6671-24139d96056a6e31.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1925\",\"static/chunks/1925-2f5cd74229e99452.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1859\",\"static/chunks/1859-70b983a36ccbddb0.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5043\",\"static/chunks/5043-2a5f351f393960fe.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"7177\",\"static/chunks/app/layout-6a22684d8d80ace6.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"S\"]\n"])

self.__next_f.push([1,"19:I[66716,[\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4391\",\"static/chunks/4391-54b9d17e6b1a0052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6671\",\"static/chunks/6671-24139d96056a6e31.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1925\",\"static/chunks/1925-2f5cd74229e99452.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1859\",\"static/chunks/1859-70b983a36ccbddb0.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5043\",\"static/chunks/5043-2a5f351f393960fe.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"7177\",\"static/chunks/app/layout-6a22684d8d80ace6.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"PostHogProvider\"]\n"])

self.__next_f.push([1,"1a:I[23052,[\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4391\",\"static/chunks/4391-54b9d17e6b1a0052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6671\",\"static/chunks/6671-24139d96056a6e31.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1925\",\"static/chunks/1925-2f5cd74229e99452.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1859\",\"static/chunks/1859-70b983a36ccbddb0.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5043\",\"static/chunks/5043-2a5f351f393960fe.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"7177\",\"static/chunks/app/layout-6a22684d8d80ace6.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"ClerkFailed\"]\n"])

self.__next_f.push([1,"1b:I[14611,[\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4391\",\"static/chunks/4391-54b9d17e6b1a0052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6671\",\"static/chunks/6671-24139d96056a6e31.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1925\",\"static/chunks/1925-2f5cd74229e99452.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1859\",\"static/chunks/1859-70b983a36ccbddb0.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5043\",\"static/chunks/5043-2a5f351f393960fe.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"7177\",\"static/chunks/app/layout-6a22684d8d80ace6.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"ErrorBoundary\"]\n"])

self.__next_f.push([1,"1c:I[96678,[\"8039\",\"static/chunks/app/error-47f7eec85e767237.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"default\"]\n1d:I[45958,[\"6874\",\"static/chunks/6874-414075bb21e16c80.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4064\",\"static/chunks/4064-7b22641ff6a9adf5.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"9905\",\"static/chunks/9905-0e99396b57501177.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6430\",\"static/chunks/6430-fc9f529a27cc0590.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5086\",\"static/chunks/app/news/%5Bid%5D/page-6fe57742c3d25052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"default\"]\n1e:I[6874,[\"6874\",\"static/chunks/6874-414075bb21e16c80.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4064\",\"static/chunks/4064-7b22641ff6a9adf5.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"9905\",\"static/chunks/9905-0e99396b57501177.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6430\",\"static/chunks/6430-fc9f529a27cc0590.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5086\",\"static/chunks/app/news/%5Bid%5D/page-6fe57742c3d25052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"\"]\n"])

self.__next_f.push([1,"1f:I[15851,[\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4391\",\"static/chunks/4391-54b9d17e6b1a0052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6671\",\"static/chunks/6671-24139d96056a6e31.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1925\",\"static/chunks/1925-2f5cd74229e99452.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1859\",\"static/chunks/1859-70b983a36ccbddb0.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5043\",\"static/chunks/5043-2a5f351f393960fe.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"7177\",\"static/chunks/app/layout-6a22684d8d80ace6.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"Toaster\"]\n"])

self.__next_f.push([1,"20:I[69243,[\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4391\",\"static/chunks/4391-54b9d17e6b1a0052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6671\",\"static/chunks/6671-24139d96056a6e31.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1925\",\"static/chunks/1925-2f5cd74229e99452.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1859\",\"static/chunks/1859-70b983a36ccbddb0.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5043\",\"static/chunks/5043-2a5f351f393960fe.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"7177\",\"static/chunks/app/layout-6a22684d8d80ace6.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"\"]\n"])

self.__next_f.push([1,"21:I[51711,[\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4391\",\"static/chunks/4391-54b9d17e6b1a0052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6671\",\"static/chunks/6671-24139d96056a6e31.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1925\",\"static/chunks/1925-2f5cd74229e99452.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1859\",\"static/chunks/1859-70b983a36ccbddb0.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5043\",\"static/chunks/5043-2a5f351f393960fe.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"7177\",\"static/chunks/app/layout-6a22684d8d80ace6.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"MicrosoftClarity\"]\n"])

self.__next_f.push([1,"22:I[96063,[\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4391\",\"static/chunks/4391-54b9d17e6b1a0052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6671\",\"static/chunks/6671-24139d96056a6e31.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1925\",\"static/chunks/1925-2f5cd74229e99452.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"1859\",\"static/chunks/1859-70b983a36ccbddb0.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5043\",\"static/chunks/5043-2a5f351f393960fe.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"7177\",\"static/chunks/app/layout-6a22684d8d80ace6.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"GoogleTagManager\"]\n"])

self.__next_f.push([1,":HL[\"/_next/static/media/4c9affa5bc8f420e-s.p.woff2?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"font\",{\"crossOrigin\":\"\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/5460c2a840a39ad9.css?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"style\"]\n:HL[\"/_next/static/css/9599bda9420163a6.css?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"style\"]\n"])

self.__next_f.push([1,"0:{\"P\":null,\"b\":\"pvj1kJbWVGGQeNjh7Jgfu\",\"p\":\"\",\"c\":[\"\",\"news\",\"77dad60c-f10c-44d9-a14e-fd54e4165c9e\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"news\",{\"children\":[[\"id\",\"77dad60c-f10c-44d9-a14e-fd54e4165c9e\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/5460c2a840a39ad9.css?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"$undefined\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/9599bda9420163a6.css?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"$undefined\"}]],\"$L2\"]}],{\"children\":[\"news\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"id\",\"77dad60c-f10c-44d9-a14e-fd54e4165c9e\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L5\",null,[\"$\",\"$L6\",null,{\"children\":[\"$L7\",[\"$\",\"$L8\",null,{\"promise\":\"$@9\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$La\",null,{\"children\":\"$Lb\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lc\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$d\",null,{\"fallback\":null,\"children\":\"$Le\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$f\",[]],\"s\":false,\"S\":false}\n"])

self.__next_f.push([1,"{\"@context\":\"https://schema.org\",\"@type\":\"Organization\",\"name\":\"Vibe Trading\",\"alternateName\":[\"Vibe Trading AI\",\"VibeTrader\",\"Vibe Trader\"],\"url\":\"https://vibetrader.com\",\"logo\":\"https://vibetrader.com/logo-small.png\",\"description\":\"AI-powered automated trading platform with real-time analytics, risk management, and no-code strategy builder for smarter trading.\",\"foundingDate\":\"2024\",\"industry\":\"Financial Technology\",\"knowsAbout\":[\"Automated forex trading\",\"Algorithmic trading\",\"AI-powered market analysis\",\"Trading risk management\",\"No-code strategy builder\",\"MetaTrader 4 automation\",\"MetaTrader 5 automation\",\"Backtesting trading strategies\",\"Trade journaling\",\"Automated trade execution\"],\"sameAs\":[\"https://x.com/_VibeTrader_\",\"https://github.com/vibetrading\",\"https://www.linkedin.com/company/vibetrading\"],\"contactPoint\":{\"@type\":\"ContactPoint\",\"email\":\"support@vibetrader.com\",\"contactType\":\"customer support\",\"availableLanguage\":\"English\"},\"offers\":{\"@type\":\"AggregateOffer\",\"offerCount\":\"3\",\"lowPrice\":\"29\",\"highPrice\":\"299\",\"priceCurrency\":\"USD\",\"offers\":[{\"@type\":\"Offer\",\"name\":\"Starter Plan\",\"price\":\"29\",\"priceCurrency\":\"USD\",\"url\":\"https://vibetrader.com/pricing\"},{\"@type\":\"Offer\",\"name\":\"Professional Plan\",\"price\":\"99\",\"priceCurrency\":\"USD\",\"url\":\"https://vibetrader.com/pricing\"},{\"@type\":\"Offer\",\"name\":\"Enterprise Plan\",\"price\":\"299\",\"priceCurrency\":\"USD\",\"url\":\"https://vibetrader.com/pricing\"}]}}"])

self.__next_f.push([1,"2:[\"$\",\"$L10\",null,{\"authPromise\":\"$@11\",\"children\":[\"$\",\"$L12\",null,{\"publishableKey\":\"pk_live_Y2xlcmsudmliZXRyYWRlci5jb20k\",\"clerkJSUrl\":\"$undefined\",\"clerkJSVersion\":\"$undefined\",\"proxyUrl\":\"\",\"domain\":\"\",\"isSatellite\":false,\"signInUrl\":\"\",\"signUpUrl\":\"\",\"signInForceRedirectUrl\":\"\",\"signUpForceRedirectUrl\":\"\",\"signInFallbackRedirectUrl\":\"\",\"signUpFallbackRedirectUrl\":\"\",\"afterSignInUrl\":\"\",\"afterSignUpUrl\":\"\",\"newSubscriptionRedirectUrl\":\"\",\"telemetry\":{\"disabled\":false,\"debug\":false},\"sdkMetadata\":{\"name\":\"@clerk/nextjs\",\"version\":\"6.39.0\",\"environment\":\"production\"},\"nonce\":\"\",\"initialState\":{\"tokenType\":\"session_token\",\"sessionClaims\":null,\"sessionId\":null,\"sessionStatus\":null,\"userId\":null,\"actor\":null,\"orgId\":null,\"orgRole\":null,\"orgSlug\":null,\"orgPermissions\":null,\"factorVerificationAge\":null,\"isAuthenticated\":false,\"user\":\"$undefined\",\"organization\":\"$undefined\"},\"children\":[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-white dark:bg-gray-950 text-black dark:text-white __className_73ee6c\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"script\",null,{\"type\":\"application/ld+json\",\"dangerouslySetInnerHTML\":{\"__html\":\"$13\"}}],[\"$\",\"script\",null,{\"type\":\"application/ld+json\",\"dangerouslySetInnerHTML\":{\"__html\":\"{\\\"@context\\\":\\\"https://schema.org\\\",\\\"@type\\\":\\\"WebSite\\\",\\\"url\\\":\\\"https://vibetrader.com\\\",\\\"name\\\":\\\"Vibe Trading\\\",\\\"description\\\":\\\"AI-powered automated trading platform\\\"}\"}}],[\"$\",\"script\",null,{\"type\":\"application/ld+json\",\"dangerouslySetInnerHTML\":{\"__html\":\"{\\\"@context\\\":\\\"https://schema.org\\\",\\\"@type\\\":\\\"SoftwareApplication\\\",\\\"name\\\":\\\"Vibe Trading Platform\\\",\\\"applicationCategory\\\":\\\"FinanceApplication\\\",\\\"operatingSystem\\\":\\\"Web, iOS, Android\\\",\\\"offers\\\":{\\\"@type\\\":\\\"AggregateOffer\\\",\\\"lowPrice\\\":\\\"29\\\",\\\"highPrice\\\":\\\"299\\\",\\\"priceCurrency\\\":\\\"USD\\\"},\\\"featureList\\\":[\\\"AI-powered market analysis\\\",\\\"Automated trade execution\\\",\\\"Real-time forex market data\\\",\\\"Risk management tools\\\",\\\"No-code strategy builder\\\",\\\"Backtesting engine\\\",\\\"Trade journaling\\\",\\\"MetaTrader 4 and MT5 integration\\\",\\\"Portfolio analytics\\\",\\\"24/7 automated monitoring\\\"]}\"}}],[\"$\",\"script\",null,{\"type\":\"application/ld+json\",\"dangerouslySetInnerHTML\":{\"__html\":\"{\\\"@context\\\":\\\"https://schema.org\\\",\\\"@type\\\":\\\"WebSite\\\",\\\"url\\\":\\\"https://vibetrader.com\\\",\\\"name\\\":\\\"Vibetrader\\\",\\\"potentialAction\\\":{\\\"@type\\\":\\\"SearchAction\\\",\\\"target\\\":\\\"https://vibetrader.com/search?q={search_term_string}\\\",\\\"query-input\\\":\\\"required name=search_term_string\\\"}}\"}}]]}],\"$L14\",\"$L15\"]}]}]}]\n"])

self.__next_f.push([1,"14:[\"$\",\"body\",null,{\"className\":\"min-h-[100dvh] bg-gray-50 dark:bg-gray-950\",\"children\":[[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"attribute\":\"class\",\"defaultTheme\":\"system\",\"forcedTheme\":\"$undefined\",\"enableSystem\":true,\"disableTransitionOnChange\":true,\"children\":[\"$\",\"$L18\",null,{\"value\":{\"fallback\":{}},\"children\":[\"$\",\"$L19\",null,{\"children\":[[\"$\",\"$L1a\",null,{\"children\":[\"$\",\"div\",null,{\"style\":{\"padding\":\"2rem\",\"textAlign\":\"center\",\"fontSize\":14,\"color\":\"#888\"},\"children\":\"Authentication is temporarily unavailable. Please refresh the page.\"}]}],[\"$\",\"$L1b\",null,{\"children\":[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1c\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"div\",null,{\"className\":\"flex items-center justify-center min-h-[100dvh]\",\"children\":[\"$\",\"div\",null,{\"className\":\"max-w-md space-y-8 p-4 text-center\",\"children\":[[\"$\",\"div\",null,{\"className\":\"flex justify-center\",\"children\":[\"$\",\"$L1d\",null,{\"ref\":\"$undefined\",\"iconNode\":[[\"circle\",{\"cx\":\"12\",\"cy\":\"12\",\"r\":\"10\",\"key\":\"1mglay\"}]],\"className\":\"lucide-circle size-12 text-orange-500\"}]}],[\"$\",\"h1\",null,{\"className\":\"text-4xl font-bold text-gray-900 tracking-tight\",\"children\":\"Page Not Found\"}],[\"$\",\"p\",null,{\"className\":\"text-base text-gray-500\",\"children\":\"The page you are looking for might have been removed, had its name changed, or is temporarily unavailable.\"}],[\"$\",\"$L1e\",null,{\"href\":\"/\",\"className\":\"max-w-48 mx-auto flex justify-center py-2 px-4 border border-gray-300 rounded-full shadow-sm text-sm font-medium text-gray-700 bg-white hover:bg-gray-50 focus:outline-none focus:ring-2 focus:ring-offset-2 focus:ring-orange-500\",\"children\":\"Back to Home\"}]]}]}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]}]]}]}]}]}],[\"$\",\"$L1f\",null,{}],[\"$\",\"$L20\",null,{\"src\":\"https://r.wdfl.co/rw.js\",\"data-rewardful\":\"6b335c\"}],[\"$\",\"$L20\",null,{\"id\":\"rewardful-queue\",\"strategy\":\"beforeInteractive\",\"children\":\"(function(w,r){w._rwq=r;w[r]=w[r]||function(){(w[r].q=w[r].q||[]).push(arguments)}})(window,'rewardful');\"}],[\"$\",\"$L21\",null,{}],[\"$\",\"$L20\",null,{\"id\":\"apollo-tracker\",\"strategy\":\"afterInteractive\",\"children\":\"\\n    function initApollo(){\\n      var n=Math.random().toString(36).substring(7),o=document.createElement(\\\"script\\\");\\n      o.src=\\\"https://assets.apollo.io/micro/website-tracker/tracker.iife.js?nocache=\\\"+n,o.async=!0,o.defer=!0,\\n      o.onload=function(){window.trackingFunctions.onLoad({appId:\\\"69e4b679e4d7f800213a01f4\\\"})},\\n      document.head.appendChild(o)\\n    }\\n    initApollo();\\n  \"}]]}]\n"])

self.__next_f.push([1,"15:[\"$\",\"$L22\",null,{\"gtmId\":\"GTM-P2G6N8HT\"}]\n11:\"$2:props:children:props:initialState\"\nb:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, maximum-scale=5, user-scalable=yes\"}]]\n7:null\n"])

self.__next_f.push([1,"23:I[38175,[],\"IconMark\"]\n"])

self.__next_f.push([1,"9:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Eli Lilly to File for Approval of Next-Generation Obesity Drug Retatrutide in 2027 After Positive Late-Stage Trials | Vibetrader\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"Eli Lilly announced that it will file for approval of its next-generation obesity drug, retatrutide, in the first quarter of 2027, following successful results...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"Vibetrader Team\"}],[\"$\",\"meta\",\"3\",{\"name\":\"keywords\",\"content\":\"financial news,market analysis,trading insights,high impact\"}],[\"$\",\"meta\",\"4\",{\"name\":\"referrer\",\"content\":\"origin-when-cross-origin\"}],[\"$\",\"meta\",\"5\",{\"name\":\"creator\",\"content\":\"Vibetrader\"}],[\"$\",\"meta\",\"6\",{\"name\":\"publisher\",\"content\":\"Vibetrader\"}],[\"$\",\"meta\",\"7\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"8\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-video-preview:-1, max-image-preview:large, max-snippet:-1\"}],[\"$\",\"meta\",\"9\",{\"name\":\"category\",\"content\":\"Finance\"}],[\"$\",\"meta\",\"10\",{\"name\":\"classification\",\"content\":\"Trading Platform\"}],[\"$\",\"meta\",\"11\",{\"name\":\"news_keywords\",\"content\":\"financial news, market analysis, trading insights, high market impact, lilly, file, approval, nextgeneration, obesity, drug\"}],[\"$\",\"meta\",\"12\",{\"name\":\"googlebot-news\",\"content\":\"index, follow\"}],[\"$\",\"link\",\"13\",{\"rel\":\"canonical\",\"href\":\"https://vibetrader.com/news/77dad60c-f10c-44d9-a14e-fd54e4165c9e\"}],[\"$\",\"meta\",\"14\",{\"name\":\"format-detection\",\"content\":\"telephone=no, address=no, email=no\"}],[\"$\",\"meta\",\"15\",{\"name\":\"google-site-verification\",\"content\":\"G-3XM7T03PEY\"}],[\"$\",\"meta\",\"16\",{\"name\":\"msvalidate.01\",\"content\":\"6313E1507216DF787F64E4BA3A18D9C7\"}],[\"$\",\"meta\",\"17\",{\"property\":\"og:title\",\"content\":\"Eli Lilly to File for Approval of Next-Generation Obesity Drug Retatrutide in 2027 After Positive Late-Stage Trials\"}],[\"$\",\"meta\",\"18\",{\"property\":\"og:description\",\"content\":\"Eli Lilly announced that it will file for approval of its next-generation obesity drug, retatrutide, in the first quarter of 2027, following successful results...\"}],[\"$\",\"meta\",\"19\",{\"property\":\"og:url\",\"content\":\"https://vibetrader.com/news/77dad60c-f10c-44d9-a14e-fd54e4165c9e\"}],[\"$\",\"meta\",\"20\",{\"property\":\"og:image\",\"content\":\"https://vibetraderapp.blob.core.windows.net/vibe-news-images/news_0a80ee44-a2d9-4307-af9d-61847f78ab55.png\"}],[\"$\",\"meta\",\"21\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"22\",{\"property\":\"article:published_time\",\"content\":\"2026-07-23T12:13:44.429656Z\"}],[\"$\",\"meta\",\"23\",{\"property\":\"article:author\",\"content\":\"Vibe Trading AI\"}],[\"$\",\"meta\",\"24\",{\"name\":\"twitter:card\",\"content\":\"summary_large_image\"}],[\"$\",\"meta\",\"25\",{\"name\":\"twitter:title\",\"content\":\"Eli Lilly to File for Approval of Next-Generation Obesity Drug Retatrutide in 2027 After Positive Late-Stage Trials\"}],[\"$\",\"meta\",\"26\",{\"name\":\"twitter:description\",\"content\":\"Eli Lilly announced that it will file for approval of its next-generation obesity drug, retatrutide, in the first quarter of 2027, following successful results...\"}],[\"$\",\"meta\",\"27\",{\"name\":\"twitter:image\",\"content\":\"https://vibetraderapp.blob.core.windows.net/vibe-news-images/news_0a80ee44-a2d9-4307-af9d-61847f78ab55.png\"}],[\"$\",\"link\",\"28\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L23\",\"29\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])

self.__next_f.push([1,"e:\"$9:metadata\"\n"])

self.__next_f.push([1,"24:I[6430,[\"6874\",\"static/chunks/6874-414075bb21e16c80.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4064\",\"static/chunks/4064-7b22641ff6a9adf5.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"9905\",\"static/chunks/9905-0e99396b57501177.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6430\",\"static/chunks/6430-fc9f529a27cc0590.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5086\",\"static/chunks/app/news/%5Bid%5D/page-6fe57742c3d25052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"Header\"]\n"])

self.__next_f.push([1,"5:[[\"$\",\"$L24\",null,{\"variant\":\"solid\"}],[\"$\",\"main\",null,{\"className\":\"min-h-screen pt-24 pb-16\",\"children\":[\"$\",\"div\",null,{\"className\":\"max-w-3xl mx-auto px-4 sm:px-6 lg:px-8\",\"children\":[[\"$\",\"script\",null,{\"type\":\"application/ld+json\",\"suppressHydrationWarning\":true,\"children\":\"{\\\"@context\\\":\\\"https://schema.org\\\",\\\"@type\\\":\\\"NewsArticle\\\",\\\"headline\\\":\\\"Eli Lilly to File for Approval of Next-Generation Obesity Drug Retatrutide in 2027 After Positive Late-Stage Trials\\\",\\\"image\\\":[\\\"https://vibetraderapp.blob.core.windows.net/vibe-news-images/news_0a80ee44-a2d9-4307-af9d-61847f78ab55.png\\\"],\\\"description\\\":\\\"Eli Lilly announced that it will file for approval of its next-generation obesity drug, retatrutide, in the first quarter of 2027, following successful results...\\\",\\\"datePublished\\\":\\\"2026-07-23T12:13:44.429656Z\\\",\\\"dateModified\\\":\\\"2026-07-23T12:13:44.429656Z\\\",\\\"author\\\":{\\\"@type\\\":\\\"Organization\\\",\\\"name\\\":\\\"Vibe Trading AI\\\",\\\"url\\\":\\\"https://vibetrader.com\\\"},\\\"publisher\\\":{\\\"@type\\\":\\\"Organization\\\",\\\"name\\\":\\\"Vibe Trading AI\\\",\\\"url\\\":\\\"https://vibetrader.com\\\",\\\"logo\\\":{\\\"@type\\\":\\\"ImageObject\\\",\\\"url\\\":\\\"https://vibetrader.com/og-image.png\\\"}},\\\"mainEntityOfPage\\\":{\\\"@type\\\":\\\"WebPage\\\",\\\"@id\\\":\\\"https://vibetrader.com/news/77dad60c-f10c-44d9-a14e-fd54e4165c9e\\\"}}\"}],[\"$\",\"script\",null,{\"type\":\"application/ld+json\",\"suppressHydrationWarning\":true,\"children\":\"{\\\"@context\\\":\\\"https://schema.org\\\",\\\"@type\\\":\\\"BreadcrumbList\\\",\\\"itemListElement\\\":[{\\\"@type\\\":\\\"ListItem\\\",\\\"position\\\":1,\\\"name\\\":\\\"Home\\\",\\\"item\\\":\\\"https://vibetrader.com\\\"},{\\\"@type\\\":\\\"ListItem\\\",\\\"position\\\":2,\\\"name\\\":\\\"News\\\",\\\"item\\\":\\\"https://vibetrader.com/news\\\"},{\\\"@type\\\":\\\"ListItem\\\",\\\"position\\\":3,\\\"name\\\":\\\"Eli Lilly to File for Approval of Next-Generation Obesity Drug Retatrutide in 2027 After Positive Late-Stage Trials\\\",\\\"item\\\":\\\"https://vibetrader.com/news/77dad60c-f10c-44d9-a14e-fd54e4165c9e\\\"}]}\"}],[\"$\",\"nav\",null,{\"className\":\"flex items-center gap-2 text-sm text-gray-500 dark:text-gray-400 mb-10\",\"children\":[\"$\",\"$L1e\",null,{\"href\":\"/news\",\"className\":\"hover:text-gray-900 dark:hover:text-white transition-colors\",\"children\":\"News\"}]}],[\"$\",\"h1\",null,{\"className\":\"text-3xl font-bold text-gray-900 dark:text-white mb-3 leading-tight\",\"children\":\"Eli Lilly to File for Approval of Next-Generation Obesity Drug Retatrutide in 2027 After Positive Late-Stage Trials\"}],[\"$\",\"div\",null,{\"className\":\"flex items-center gap-2 mb-4\",\"children\":[[\"$\",\"span\",null,{\"className\":\"inline-flex items-center text-xs font-medium text-purple-600 dark:text-purple-400 bg-purple-100 dark:bg-purple-500/10 rounded-full px-2.5 py-0.5\",\"children\":[\"Bullish\",\" \",\"(\",\"0.8\",\")\"]}],[\"$\",\"span\",null,{\"className\":\"inline-flex items-center text-xs font-medium text-purple-600 dark:text-purple-400 bg-purple-100 dark:bg-purple-500/10 rounded-full px-2.5 py-0.5\",\"children\":[\"Impact: \",\"High\"]}]]}],[\"$\",\"p\",null,{\"className\":\"text-sm text-gray-500 mb-8\",\"children\":[\"Published on \",\"July 23, 2026\",\" (\",\"12 days ago\",\") · By Vibe Trader\"]}],[\"$\",\"div\",null,{\"className\":\"relative w-full aspect-video rounded-xl overflow-hidden mb-8 shadow-md border border-gray-200 dark:border-white/[0.08]\",\"children\":[\"$\",\"img\",null,{\"src\":\"https://vibetraderapp.blob.core.windows.net/vibe-news-images/news_0a80ee44-a2d9-4307-af9d-61847f78ab55.png\",\"alt\":\"Eli Lilly to File for Approval of Next-Generation Obesity Drug Retatrutide in 2027 After Positive Late-Stage Trials\",\"className\":\"w-full h-full object-cover\"}]}],[\"$\",\"article\",null,{\"className\":\"mb-10\",\"children\":[[\"$\",\"p\",\"0\",{\"className\":\"text-sm text-gray-600 dark:text-gray-300 leading-relaxed mb-2\",\"children\":\"Eli Lilly announced that it will file for approval of its next-generation obesity drug, retatrutide, in the first quarter of 2027, following successful results from two additional late-stage trials [1]. The company had previously indicated it might submit an application as early as this year, but now states that more time is needed to gather and verify manufacturing and quality-control data required by regulators [1].\"}],\"$L25\",\"$L26\",\"$L27\",\"$L28\",\"$L29\",\"$L2a\",\"$L2b\",\"$L2c\",\"$L2d\",\"$L2e\",\"$L2f\"]}],\"$L30\",\"$L31\",\"$L32\",\"$L33\"]}]}]]\n"])

self.__next_f.push([1,"34:I[76966,[\"6874\",\"static/chunks/6874-414075bb21e16c80.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"4064\",\"static/chunks/4064-7b22641ff6a9adf5.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"2256\",\"static/chunks/2256-313405c0b02d0c86.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"3965\",\"static/chunks/3965-94f3fbfa6e85419f.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"9905\",\"static/chunks/9905-0e99396b57501177.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"6430\",\"static/chunks/6430-fc9f529a27cc0590.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\",\"5086\",\"static/chunks/app/news/%5Bid%5D/page-6fe57742c3d25052.js?dpl=dpl_5r29GGcpDhM2aFwH5wGE47bgVAud\"],\"ArticleFeedback\"]\n25:[\"$\",\"div\",\"1\",{\"className\":\"h-3\"}]\n"])

self.__next_f.push([1,"26:[\"$\",\"p\",\"2\",{\"className\":\"text-sm text-gray-600 dark:text-gray-300 leading-relaxed mb-2\",\"children\":\"In the two phase three trials, retatrutide demonstrated significant weight loss and improvements in blood sugar levels among adults with obesity and either Type 2 diabetes or established cardiovascular disease [1]. Specifically, adults with obesity and diabetes lost up to an average of 20.8% of their weight, or nearly 50 pounds, at 80 weeks, while those with severe obesity and established cardiovascular disease lost up to an average of 22.6% of their weight, or 55.8 pounds, at 80 weeks [1]. The drug also meaningfully reduced certain cardiovascular risk factors, according to Lilly [1].\"}]\n"])

self.__next_f.push([1,"27:[\"$\",\"div\",\"3\",{\"className\":\"h-3\"}]\n28:[\"$\",\"p\",\"4\",{\"className\":\"text-sm text-gray-600 dark:text-gray-300 leading-relaxed mb-2\",\"children\":\"The side effects observed were consistent with previous studies and included diarrhea, nausea, and constipation, which are common across the GLP-1 class of drugs [1]. Retatrutide has now shown positive results in five late-stage trials and is being positioned as the next pillar of Lilly's obesity portfolio, following its injection Zepbound and the newly launched pill, Foundayo [1].\"}]\n29:[\"$\",\"div\",\"5\",{\"className\":\"h-3\"}]\n"])

Requests	IP Address	Location	AS Autonomous System
75	216.150.1.1	United States	AS16509Amazon.com, Inc.
75	1	-	-

Security Scan Report: vibetrader.com

Summary

AI Security Verdict

Safe Website

Safety Factors

Details

Screenshot

Page Load Overview

Language Analysis

Primary Language

Detection Details

Website Classification

Primary Category

All Detected Categories

Detected Features

Domain & IP Information

Detected Technologies8

Content Similarity HashesFor malware variant detection

TLSH (Trend Micro Locality Sensitive Hash)

ssdeep (Context Triggered Piecewise Hashing)

sdhash (Similarity Digest Hashing)

Image Hashes

Perceptual Hashes

Other Hashes

Scan History